In line with the latter, genetic alterations frequently implicate ZEB2 in various translocations and mutations within T-lymphoid leukemia and AML, with 14q32 rearrangements involving the BCL11B gene marking a distinct subgroup. This evidence concerns the gene ZEB2 and acute myeloid leukemia.